NCI Seeks to Develop Digital Device

The National Cancer Institute’s (NCI) https://www.ott.nih.gov Office of Technology Transfer seeks licenses to develop an automated digital pathology device.

The device would be used for biopsy sample processing and be applicable to diagnose various disease indications, including cancer and infectious diseases. NCI recognizes the need for automation of the techniques used in processing pathology samples and the need for digital images to make them usable with high-throughput approaches like Artificial Intelligence (AI) analysis.

These automated techniques are required because demand for AI in three-dimensional (3D) reconstruction in digital pathology has increased and the demand can’t be met by a time consuming manual process.

Inventors at NCI are developing an automated device with integrated tissue sectioning, staining, scanning, and high throughput capability. This device integrates pathology sample processing with optical scanning and digital image acquisition to facilitate processing and imaging of large volumes of pathology samples that must be compatible with AI analysis of digital pathology images and 3D reconstruction.

For information on licensing and information for applications, contact Michael Salgaller, PhD, at michael.salgaller@nih.gov or call 240-276-5476. For more details on the Licensing Opportunity for Automated Digital Pathology Device go to NIH’s Office of Technology Transfer at https://www.ott.nih.gov/news/licensing-opportunity-for-an-automated-digital-pathology-device